Stockscreener 앱 받기
1.35
2.17%
-0.03
시간 외 거래:
1.33
-0.02
-1.48%
전일 마감가:
$1.38
열려 있는:
$1.35
하루 거래량:
272.96K
Relative Volume:
1.48
시가총액:
$42.11M
수익:
$81,000
순이익/손실:
$-41.04M
주가수익비율:
-1.0251
EPS:
-1.3169
순현금흐름:
$-30.69M
1주 성능:
-8.78%
1개월 성능:
-14.56%
6개월 성능:
-12.90%
1년 성능:
-23.30%
1일 변동 폭
$1.33
$1.40
1주일 범위
$1.33
$1.48
52주 변동 폭
$1.06
$2.41
Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile
명칭
Actinium Pharmaceuticals Inc
전화
646-767-3870
주소
275 Madison Avenue, 7th Floor, New York, NY
ATNM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATNM
Actinium Pharmaceuticals Inc
|
1.35 | 43.05M | 81,000 | -41.04M | -30.69M | -1.3169 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-07 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-02-21 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-09-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-08-25 | 개시 | B. Riley Securities | Buy |
| 2020-11-05 | 개시 | Alliance Global Partners | Buy |
| 2017-12-06 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-10-23 | 재개 | ROTH Capital | Buy |
| 2017-09-14 | 개시 | Maxim Group | Buy |
| 2016-08-25 | 개시 | ROTH Capital | Buy |
| 2016-02-29 | 개시 | H.C. Wainwright | Buy |
| 2015-10-15 | 개시 | FBR Capital | Outperform |
| 2014-10-01 | 개시 | MLV & Co | Buy |
| 2014-07-22 | 개시 | Canaccord Genuity | Buy |
모두보기
Actinium Pharmaceuticals Inc 주식(ATNM)의 최신 뉴스
Is Actinium Pharmaceuticals Inc. (7AY1) stock a momentum leaderJuly 2025 Macro Moves & Low Risk High Win Rate Stock Picks - newser.com
Actinium Pharmaceuticals, Inc. to Highlight ATNM-400 Data in Hormone-Resistant and HER2-Resistant Breast Cancer at the 2025 San Antonio Breast Cancer Symposium, Expanding Pan-Tumor Profile Across Three Solid Tumor Indications - PR Newswire
Can you recover from losses in Actinium Pharmaceuticals Inc.Watch List & Technical Buy Zone Confirmation - newser.com
Identifying reversal signals in Actinium Pharmaceuticals Inc.Weekly Investment Report & Community Trade Idea Sharing - newser.com
How buybacks impact Actinium Pharmaceuticals Inc. stock valueJuly 2025 Sector Moves & Stepwise Entry and Exit Trade Signals - newser.com
Why retail traders accumulate Actinium Pharmaceuticals Inc. (Delaware) stockJuly 2025 PostEarnings & Stepwise Swing Trade Plans - newser.com
What momentum shifts mean for Actinium Pharmaceuticals Inc.2025 Top Gainers & Reliable Price Breakout Signals - newser.com
Will Actinium Pharmaceuticals Inc. (7AY1) stock outperform foreign stocks2025 Bull vs Bear & AI Powered Market Trend Analysis - newser.com
How Actinium Pharmaceuticals Inc. (Delaware) stock expands through international marketsTrade Signal Summary & Verified Stock Trade Ideas - newser.com
How moving averages guide Actinium Pharmaceuticals Inc. tradingWeekly Profit Summary & Weekly High Potential Stock Alerts - newser.com
Is Actinium Pharmaceuticals Inc. stock ready for a breakoutJuly 2025 Fed Impact & Community Verified Trade Signals - newser.com
Actinium Pharma (NYSE American: ATNM) to join Stephens fireside chat; one-on-one meetings - Stock Titan
How supply shortages influence Actinium Pharmaceuticals Inc. (Delaware) stockPortfolio Gains Report & Weekly Market Pulse Alerts - newser.com
Is Actinium Pharmaceuticals Inc. stock a smart buy before Fed meetingProduct Launch & Fast Entry Momentum Alerts - newser.com
How Actinium Pharmaceuticals Inc. stock performs in rate cut cycles2025 Trade Ideas & Accurate Buy Signal Notifications - newser.com
Is Actinium Pharmaceuticals Inc. stock entering bullish territoryJuly 2025 Closing Moves & Stepwise Trade Execution Plans - newser.com
How Actinium Pharmaceuticals Inc. (Delaware) stock stacks up against competitors2025 Year in Review & Low Risk High Reward Trade Ideas - newser.com
Has Actinium Pharmaceuticals Inc. found a price floorIndex Update & AI Driven Stock Reports - newser.com
Why Actinium Pharmaceuticals Inc. (Delaware) stock stays undervaluedMarket Volume Summary & AI Based Buy and Sell Signals - newser.com
How Actinium Pharmaceuticals Inc. (Delaware) stock responds to bond marketJuly 2025 Volume & Fast Moving Market Watchlists - newser.com
Will Actinium Pharmaceuticals Inc. (7AY1) stock gain from lower interest ratesQuarterly Market Summary & Community Consensus Trade Alerts - newser.com
Published on: 2025-10-31 04:06:04 - newser.com
Is Actinium Pharmaceuticals Inc. (Delaware) stock a buy on weaknessWeekly Risk Report & AI Powered Buy and Sell Recommendations - newser.com
Actinium Pharmaceuticals Inc (ATNM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):